Editorial Policy
This page documents how the content on HairRestorationSupply is produced, what standards it must meet before publication, and what happens when we get something wrong. It exists so that readers — professional buyers making real purchasing decisions — can judge for themselves how much weight to give what they read here.
How content is produced
Every article is written and reviewed by our editorial team, people with direct working knowledge of hair restoration instruments, manufacturing and international trade. Content is specification-first: we describe instruments and products through measurable properties — dimensions, materials, geometries, process steps — before any qualitative judgment, and we prefer a concrete number to a flattering adjective wherever a number can honestly be stated.
Articles are planned around a single buying question each, drafted against the technical facts of the category, and reviewed before publication for accuracy, completeness and compliance with the standards on this page. Each of our six language versions is written natively for its market, not machine-translated.
Sourcing standards
- We rely on public, verifiable information: published product specifications, general industry knowledge, and manufacturing practice we can describe from direct experience.
- We do not invent evidence. No fabricated statistics, no fictional studies, no invented testimonials or review counts. If we cannot state a figure confidently, we write qualitatively or omit it.
- We do not make certification or regulatory-status claims about any brand or product. Regulatory documentation is a matter between a manufacturer, its authorities and its customers — buyers should verify it in the purchasing process, and our guides tell them to.
- Where evidence for a clinical or ingredient claim is genuinely mixed, we say so rather than picking the convenient reading.
Ownership and independence
This platform is operated by the team behind Bind Pharma, an Istanbul-based manufacturer of hair restoration instruments and products. We disclose this prominently — here and on the about page — because readers deserve to know the vantage point of what they read.
The working rules that keep educational content honest: educational articles mention Bind Pharma at most once and only where genuinely relevant, and most mention it not at all; comparison content treats all brands with the same neutral, factual descriptors; and commercial intent is confined to clearly commercial pages — wholesale, OEM and private label and the distributor program — which are labeled as what they are.
Corrections
If you find an error — technical, factual or in translation — contact us with the page URL and a description of the problem. A team member reviews every report. Confirmed errors are corrected in the text directly and the page's updated date is revised; where a correction materially changes the meaning of previously published guidance, we note the change on the page rather than correcting silently. We aim to review reports within a few business days.
Feedback
Suggestions for topics, disagreements with our conclusions and requests for greater depth on a subject are all welcome through the contact page. The most useful pages on this platform exist because a reader asked a question we had not answered yet.